Optimind Pharma Corp. (CSE:OMND)
0.0050
0.00 (0.00%)
Aug 5, 2025, 1:15 PM EDT
Paramount Global Revenue
Optimind Pharma had revenue of 35.71K CAD in the quarter ending May 31, 2025, with 122.47% growth. This brings the company's revenue in the last twelve months to 138.02K, up 41.22% year-over-year. In the fiscal year ending February 28, 2025, Optimind Pharma had annual revenue of 118.37K, down -3.73%.
Revenue (ttm)
138.02K
Revenue Growth
+41.22%
P/S Ratio
3.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
515.74K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 28, 2025 | 118.37K | -4.59K | -3.73% |
Feb 29, 2024 | 122.96K | -47.15K | -27.72% |
Feb 28, 2023 | 170.11K | 70.42K | 70.64% |
Feb 28, 2022 | 99.69K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition